| |
 |
This is the category page. Below are all of the research programs that are associated with it
- Abdominal Aortic Aneurysms:
ENDOVASCULAR REPAIR USING THE TALENT™ ABDOMINAL STENT GRAFT SYSTEM IN ABDOMINAL AORTIC ANEURYSMS (VITALITY)
This study is for patients diagnosed with abdominal aortic or aortoiliac aneurysm who meet criteria to use the Talent Abdominal Stent Graft System in the endovascular repair of abdominal aortic aneurysms. Participants will be followed for 5 years and will need to be followed at set time points throughout the 5 years. A physical exam and radiological assessment of the implanted graft will be done at each of the follow-up office visits.
- Burn Scars -
ASSESSMENT OF HAIR DENSITY AND TISSUE DENSITY IN BURN SCARS USING HIGH FREQUENCY ULTRASOUND IMAGING (Investigator Initiated Protocol)
(1_20080111_118)
After participant being consented, areas of scarring are imaged with the high-resolution ultrasound device. This non-invasive imaging technique allows a real time image through all layers of skin. The full extent of scar evaluation with this tool has not been established. Hair density and adnexae density can be seen and evaluated. For study purposes, the thickness of the scan can also be measured in millimeters. An area of similar healthy skin will be examined on the same subject for each 2x2 cm area scar examined for comparison. Digital photographs will be taken of all investigated sites. The information obtained will be used to compare the scar tissue and the normal health tissue.
- Burns -
A RANDOMIZED COMPARISON STUDY OF A FLEXIBLE HYDROGEL NANOPARTICLE WOUND DRESSING WITH SILVER (ALTRAZEAL™ SILVER) VERSUS A SODIUM CARBOXYMETHYLCELLULOSE DRESSING WITH SILVER (AQUACEL® AG) FOR PARTIAL THICKNESS SKIN DONOR SITES (Protocol #UC-8U1207)
(2_20081113_118)
This is a multi-centered, randomized trial to study wound healing using Altrazeal ™ Silver Dressing compared to Aquacel AG® in patients with at least two partial thickness donor sites. A total of 45 participants will be enrolled at 3-4 sites in the US. Participants will be monitored daily while in the hospital and then must return every 2-3 days as outpatients for wound healing evaluations until wound closure or Day 24. Wound healing, pain at the site and adverse events will be assessed. Photos will also be taken at study visits. Participants will be required to return for a long-term follow-up visit at 4-6 months after wound healing for final study assessments.
- ISOLATED LIMB INFUSION REGISTRY PROTOCOL
(2_20080910_118)
This study is to open a database for any patient who has or will have Isolated Limb Infusions of a leg or arm. This study is for participants with melanoma and/or sarcoma. This registry will have no end date, it will be ongoing.
- Scarring from burns or other:
FRACTIONAL ER: GLASS PHOTOTHEMOLYSIS LASER THERAPY TO TREAT HYPERTROPHIC SCARRING (Investigator Initiated Protocol)
(2_20090409_118)
This study will be using laser treatment on scars from burns or other; to see if there is a better response than standard of care which is a topical cream or surgical modification. Participants must have at least one large scar that can be treated half with the topical cream and the other half with the laser; or have two similar scars. The scarring must beat least 2 months, but not longer than 5 years. Participants will need to undergo scar measurements and treatments. Potential benefits are hoped to be decreased scarring, redness and itching of the scar.
- Spinal Stenosis -
CLINICAL STUDY COMPARING DYNAMIC STABILIZATION OF THE LUMBAR SPINE WITH THE STABILIMAX NZ® DYNAMIC SPINE STABILIZATION SYSTEM TO POSTEROLATERAL INSTRUMENTED FUSION
(1_20080303_118)
This study is for the use of an investigational device that will be implanted in the spine. This study is for patients with clinically symptomatic spinal stenosis at one or two contiguous vertebral levels from L1-S1. Participants will need to complete a set of questionnaires regarding back pain and leg pain and physical function. Participants will be randomized to either the Stabilimax device or fusion. X-rays will be taken at the time of discharge and throughout the study for up to five years to evaluate the position of the device/fusion. Questionnaires will need to be completed at each visit.
- Study Closed to Accrual -
Hip Replacement -
ZIMMER HIP REGISTRY (PROTOCOL #04-500)
(2_20070718_118)
This is a registry study, there are a limited number of possible participants. This is a prospective, multicenter registry involving orthopedic surgeons skilled in total and hemi hip replacement. Each case enrolled in the registry will receive primary or revision total hip arthroplasty using a Zimmer hip implant. Optional centralization devices and related aceteabulum components of choice will also be evaluated as a part of this protocol. All participants will have preoperative and postoperative physical exams and radiographic evaluations. Follow-up examinations will be conducted at 2-6 weeks from hospital discharge (optional), again at 3-6 months (optional) and annually thereafter for a period of 5 years.
- Study Closed to Accrual -
Knee Replacement -
ZIMMER KNEE REGISTRY (PROTOCOL #04-400)
(2_20070714_118)
This is a prospective, multicenter registry involving orthopedic surgeons skilled in total knee replacement. Each case enrolled in the registry will receive primary or revision total knee arthroplasty using Zimmer knee implants. All patients will be selected according to the patient selection criteria. All patients will have preoperative and postoperative physical and radiographic evaluations. Follow-up evaluations will be conducted at 2-6 weeks from hospital discharge, again at 3-6 months and annually thereafter for a period of 5 years.
- Study Closed to Accrual:
Burn Patients -
VASCULAR LASER TREATMENT OF BURN SCARS TO INFLUENCE HYPERTROPHIC SCARRING (Investigator Initiated)
(1_20080610_118)
This study is open for burn patients to treat hypertrophic (red, raised, irregular) scarring following the scar’s healing phase. Participants see in the B urn Recovery Center at Lehigh Valley Hospital will be approached to participate. The Laser will be used on one of the two scars. The participants will need to return to hospital and stated times for follow-up and to have their scars measured for outcomes.
- Study Closed to Accrual:
Diabetic Foot Ulcer Follow-up -
A LONG TERM FOLLOW-UP STUDY OF SUBJECTS WHO WERE PREVIOUSLY ENROLLED ON TISSUE REPAIR COMPANY-SPONSORED CLINICAL TRIALS USING GAM501 (Protocol #SWHI-02)
(2_20080811_118)
This is a long term follow-up study for people previously enrolled in the Tissue Repair Company Sponsored Clinical Trials using GAM501. Under this part of the study, participants will receive by US mail, a questionnaire from the sponsor, to fill out and send back about 6 months following completion of the first study.
- Upper Extremity Surgery -
A RANDOMIZED TRIAL, ULTRASOUND VISUALIZATION VERSUS ELECTRICAL NERVE STIMULATION FOR THE SAFETY AND EFFECTIVENESS OF INTERSCALENE NERVE BLOCK IN UPPER EXTREMITY SURGERY (Investigator Initiated Protocol, Version #3)
(2_20061012_118)
Patients will be randomized to receive one of two nerve localization techniques in a 1:1 randomization ratio. The randomization will be performed using a random generated table provided by the health studies. The patient assignments will be transferred into envelopes that will be opened at the time of enrollment and the assigned randomization group will be communicated to the anesthesiologist. Primary intraoperative providers of supplemental sedative, additional local anesthetic infiltration or analgesia, general anesthesia and assessors of VAS or PCI will be blinded to the technique. Participants will be recruited prior to their surgery.
|
|
